feed,title,long_url,short_url
SeekingAlpha,Akero Therapeutics' efruxifermin meets primary endpoint in mid-stage NASH trial,https://seekingalpha.com/news/3713698,
SeekingAlpha,Newegg stock falls 30% as retail interest grows,https://seekingalpha.com/news/3713700,
